The maker of Ozempic isxa0funding a newxa0Nvidia-powered AI supercomputer

The owner of a prominent pharmaceutical company is funding the development of a supercomputer aimed at discovering new medicines and treatments. The Novo Nordisk Foundation has awarded a contract to build one of the world’s most powerful supercomputers, capable of processing vast amounts of data using AI. The supercomputer, named Gefion, will be available for use by researchers in Denmark and is expected to accelerate scientific discoveries in areas such as drug discovery and disease diagnosis. The project highlights the potential of AI in speeding up scientific research.